A Phase II Study of Temozolomide in the Treatment of Children With High Grade Glioma.
Phase of Trial: Phase II
Latest Information Update: 18 May 2018
At a glance
- Drugs Temozolomide (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma; Gliosarcoma
- Focus Adverse reactions; Therapeutic Use
- 18 Nov 2007 Status changed from in progress to completed.
- 06 Sep 2005 New trial record.